Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.75
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $601.2K |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | −$601.0K |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $38.4K | $1.4K | $5.3K | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$1.2M | −$780.0K | −$976.1K | −$540.0K | −$737.0K | −$511.0K | −$635.9K | −$601.0K |
| EBITDA | $0 | −$1.1M | −$956.4K | −$789.0K | −$737.0K | −$511.0K | −$636.0K | −$601.0K |
| Net income | $242.6K | −$1.1M | −$973.9K | −$559.0K | −$758.0K | −$560.0K | −$670.6K | −$639.0K |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | 0.00 | -0.01 | -0.01 | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 |
Annual figures · source: Financial Modeling Prep
REGENICIN INC
No one on the platform currently holds RGIN.
No tracked institution reports a position in RGIN as of their last filing.
No one on the platform has traded RGIN yet.
| $150 |
| — |
| QBIOQ BioMed Inc. | $0.00 | -0.00% | $14509 | — |
| RCARRenovaCare, Inc. | $0.00 | +0.00% | $8735 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.